Abstract
In appraising oncology therapies, National Institute for Health and Care Excellence (NICE) evaluates clinical and cost-effectiveness vs standard of care; the impact of unmet need on recommendations is unclear. We surveyed NICE appraisal outcomes using line of therapy (LoT) and comparator therapy class as surrogate measures of unmet need.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
